Medical News

May 5, 2000 - Boulder, Colorado. MIQS, Inc., a leading developer of healthcare information technology solutions, today announced the appointment of Stephen P. Pollak as Senior Vice President and Chief Technology Officer. Mr. Pollak served as President and CEO since co- founding the company, helping to expand its customer base to over 1,000 users. In his new role, he will focus on product and business development in conjunction with the company’s expansion plans over the coming months. Mr. Pollak has a PhD in bioinformatics from the University of Sussex in England.

About his new role, Mr. Pollak commented “Healthcare is changing very rapidly, and we intend to be a leader in meeting the many technical and business challenges that face the industry today. I am delighted about continuing to help the MIQS team make this happen.”

James McGroddy, the Board Chairman of MIQS, said “Mr. Pollak’s vision and leadership has helped MIQS to create one of the most exciting IT products in healthcare today. We are delighted that he can now focus full-time on expanding the compay’s highly innovative product line.”

MIQS is a supplier of the Disease Manager Plus(TM) and MediLink(TM) suite of information technology products, built around a comprehensive electronic medical record, that support a broad set of clinical and administrative applications in healthcare. The MIQS application has been demonstrated to enable both better clinical outcomes and substantially reduced costs in caring for chronically ill patients, such as those with end stage renal disease.

For additional information, please see our web site at www.miqs.com or call us at (800) 998-6680.

May 5, 2000 - Boulder, Colorado. MIQS, Inc., a leading developer of healthcare information technology solutions, today announced the appointment of Stephen P. Pollak as Senior Vice President and Chief Technology Officer. Mr. Pollak served as President and CEO since co- founding the company, helping to expand its customer base to over 1,000 users. In his new role, he will focus on product and business development in conjunction with the company’s expansion plans over the coming months. Mr. Pollak has a PhD in bioinformatics from the University of Sussex in England.

About his new role, Mr. Pollak commented “Healthcare is changing very rapidly, and we intend to be a leader in meeting the many technical and business challenges that face the industry today. I am delighted about continuing to help the MIQS team make this happen.”

James McGroddy, the Board Chairman of MIQS, said “Mr. Pollak’s vision and leadership has helped MIQS to create one of the most exciting IT products in healthcare today. We are delighted that he can now focus full-time on expanding the compay’s highly innovative product line.”

MIQS is a supplier of the Disease Manager Plus(TM) and MediLink(TM) suite of information technology products, built around a comprehensive electronic medical record, that support a broad set of clinical and administrative applications in healthcare. The MIQS application has been demonstrated to enable both better clinical outcomes and substantially reduced costs in caring for chronically ill patients, such as those with end stage renal disease.

For additional information, please see our web site at www.miqs.com or call us at (800) 998-6680.